Pricing Log in Create free account
Saturday 17 October 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

299.77 6.47 −2.11%
Market cap
$14.6B
P/E
0.0×
Fwd P/E
29.6×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Charles River Laboratories International, Inc. (CRL) P/E ratio

Alert me on P/E ratio

Charles River Laboratories International, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 1,056× (January 2025) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 1,026× 3,954.06%
FY2023 25.3× 10.85%
FY2022 22.8× (52.94%)
FY2021 48.5× 42.45%
FY2020 34.0× 15.21%
FY2019 29.5× 22.70%
FY2018 24.1× (43.63%)
FY2017 42.7× 84.22%
FY2016 23.2× (7.40%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 1,056×
Ten-year median 26.5×
Current reading's percentile 13

P/E ratio against peers

Company P/E ratio
TWST Twist Bioscience Corporation compare n/m
GH Guardant Health, Inc. compare n/m
CRL Charles River Laboratories International, Inc. n/m
QGEN QIAGEN N.V. compare 23.6×
DGX Quest Diagnostics Incorporated compare 24.6×
LH Labcorp Holdings Inc. compare 26.2×
MEDP Medpace Holdings, Inc. compare 35.6×
RVTY Revvity Inc. compare 72.7×
ICLR ICON PLC compare 254×
Diagnostics & Research industry median 35.6×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on CRL